The Wall Street Journal
@wsj·6.6M subscribers·28.9K videos
Rep. Duckworth Questions Mylan CEO on EpiPen Sales to Schools
Posted
September 22, 2016
Views
12,836
Likes
132
Comments
21
Engagement
September 22, 2016
12,836
132
21
1.19%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
4:30Now PlayingMylan CEO Heather Bresch responded to questions Wednesday from the House Oversight Committee regarding costs of the EpiPen and the price and conditions for the sale of the item to schools. The company raised the list price of the allergy medication 548% over the last nine years, reigniting public outrage over drug prices.
Subscribe to the WSJ channel here:
More from the Wall Street Journal:
Visit WSJ.com
Follow WSJ on Facebook
Follow WSJ on Google+
Follow WSJ on Twitter
Follow WSJ on Instagram
Follow WSJ on Pinterest
Don’t miss a WSJ video, subscribe here
More from the Wall Street Journal:
Visit WSJ.com
Visit the WSJ Video Center
On Facebook
On Snapchat
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
